The Apollo + Oura Sleep Study, Explained
Executive Briefing
Bottom Line: 474,852 nights of real-world data. 935 users. A real preprint, not yet independently peer-reviewed.
2026 Metric: Among sub-six-hour sleepers, nighttime Apollo use was associated with 46 additional minutes of sleep and a 77% lower likelihood of another short night.
Access: Apollo Neuro: WZ Executive Protocol.
Apollo Neuroscience published a real-world dataset in 2026: 474,852 nights of sleep from 935 people who wore both Apollo Neuro and an Oura Ring over roughly three years.
The study is posted as a JMIR preprint. Apollo's own blog post about it calls it "peer-reviewed." We could not independently confirm that status from the preprint page itself, so this article labels it a preprint until that's verified.
What the Data Actually Shows
The headline finding applies to a specific group: people who regularly slept fewer than six hours a night. In that group, nighttime Apollo use was associated with an average of 46 additional minutes of sleep per night.
The same group showed a 77% lower likelihood of experiencing another sub-six-hour night. Apollo's materials describe a dose-dependent pattern — more consistent nighttime use linked to larger improvements.
The study also reports more REM sleep associated with Apollo use, with deep sleep described as preserved rather than reduced. The source material gives no specific percentage for either the REM increase or the deep-sleep preservation claim, so we're not assigning numbers to those two findings.
What the Study Reports (2026 Preprint)
| Metric | Reported Figure |
|---|---|
| Total nights of data | 474,852 |
| Participants | 935 |
| Study window | ~3 years |
| Added sleep (sub-6hr sleepers) | +46 min/night average |
| Reduced odds of a sub-6hr night | −77% |
| REM sleep | Reported increase, no percentage given |
| Deep sleep | Reported as preserved, no percentage given |
Source: Apollo Neuroscience, "Association Between Duration of Transcutaneous Vibratory Stimulation Delivered by the Apollo Neuro Device and Extension of Total Sleep Time," JMIR preprint, 2026, via apolloneuro.com/blogs/news/apollo-oura-jmir. Company-published; not independently peer-reviewed as of this writing.
What This Study Doesn't Prove
This is an observational, real-world dataset, not a randomized controlled trial of sleep duration. It shows an association between Apollo use and more sleep in this population — not proof that Apollo caused the increase for every person in it.
People choosing to use Apollo overnight may differ from people who don't in ways the study can't fully separate out. That's a limitation of real-world data generally, not a flaw specific to this study.
This sleep dataset is distinct from the anxiety-focused claims made elsewhere about Apollo Neuro, which we could not independently verify against a published RCT. See our standalone Apollo Neuro review for that assessment.
Frequently Asked Questions
As of October 2026 it is posted as a JMIR preprint, which has not completed independent peer review.
Apollo's own blog post describing the study calls it peer-reviewed; we could not independently confirm that status from the preprint page itself, so we label it a preprint pending verification.
Among people who regularly slept under six hours a night, nighttime Apollo Neuro use was associated with an average of 46 additional minutes of sleep per night and a 77% lower likelihood of another sub-six-hour night, drawn from 474,852 nights of Oura Ring data across 935 users over roughly three years.
No. It's an observational, real-world association study, not a randomized controlled trial of sleep duration specifically.
It shows Apollo use was associated with more sleep in this population, not that it caused the increase in every individual case.
Editorial Integrity
This study was funded and published by Apollo Neuroscience, an affiliate partner, disclosed per FTC guidelines. We report the preprint status plainly rather than adopting the company's "peer-reviewed" framing without independent confirmation.
Full policy at disclosures.